New Bluesight for Controlled Substances Feature: Investigation Portfolios
New Bluesight for Controlled Substances Feature: Investigation Portfolios
We are excited to announce the launch of our newest feature for the Bluesight for …
Kit Check Announces the Latest Bluesight for Controlled Substances Feature, Investigation Portfolios
Workflow collaboration tool helps hospitals locate possible diverters with accuracy Washington DC, June 25, 2019 …
The Data Science Behind Drug Diversion Detection with Bluesight for Controlled Substances
Data science has emerged as an ally for hospital directors of pharmacy in the continuous …
50 Hospitals Adopt Bluesight for Controlled Substances to Reconcile Discrepancies Faster, Implement 100% Audit and Close the Diversion Gap
Kit Check introduced Bluesight for Controlled Substances (BCS) in 2017 at ASHP Midyear. At the …
Video: How to Close the Diversion Gap
Kevin MacDonald, co-founder and CEO of Kit Check, at the Heath Connect Partners fall conference…
ZDNet Interviews Kevin MacDonald On Using AI to Prevent Opioid Diversion
Over 500 hospitals now use Kit Check’s automated medicated management solution to track medications from …
ZDNet Video Interview: How machine learning and AI can help detect opioid theft
The misuse and addiction of opioids has sparked a crisis across the United States, including …
Kit Check Closes the Diversion Gap with Launch of Bluesight IRIS and Reveals Which Hospital Employees Exhibit Behaviors Consistent with Controlled Substance Theft
Leading Automated Medication Solutions Provider for Hospital Pharmacies Leverages Machine Learning to Enhance Diversion Identification …